NCT00418626View on ClinicalTrials.gov

Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

September 30, 2007

Conditions
Healthy
Interventions
DRUG

Nilotinib

Trial Locations (1)

23249

Richmond

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY